A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01).
Jung-Yun LeeMyong Cheol LimByoung Gie KimNatalie Yan Li NgoiChel Hun ChoiSang-Yoon ParkDavid Shao Peng TanYunjung GoJung-Yun LeePublished in: Journal of gynecologic oncology (2021)
ClinicalTrials.gov Identifier: NCT04361370, Clinical Research Information Service Identifier: KCT0005144.